Implementation of the SRA Declan OBrien Chairman Executive Board European Technology Platform for Gl - PowerPoint PPT Presentation

1 / 7
About This Presentation
Title:

Implementation of the SRA Declan OBrien Chairman Executive Board European Technology Platform for Gl

Description:

Priority 1: targets that are achievable in the short-mid term ... in the mid-long term (brucellosis, tuberculosis, some antiparasitic vaccines... – PowerPoint PPT presentation

Number of Views:59
Avg rating:3.0/5.0
Slides: 8
Provided by: Florenti8
Category:

less

Transcript and Presenter's Notes

Title: Implementation of the SRA Declan OBrien Chairman Executive Board European Technology Platform for Gl


1
Implementation of the SRADeclan
OBrienChairmanExecutive BoardEuropean
Technology Platform for Global Animal Health
(ETPGAH)
2
Implementation of SRA
  • SRA states Research Priorities
  • Funding is required to engage in this Research
  • Collaborative Research may be required
  • Establish Costs Timetables
  • Need to complete Gap Analysis in Chapter 3

3
Priorities
  • Priority 1 targets that are achievable in the
    short-mid term
  • Priority 2 targets that are potentially
    achievable in the mid-long term (brucellosis,
    tuberculosis, some antiparasitic vaccines, oral
    vaccination (for selected targets)
  • Priority 3  Ideal World Projects  (Long-term)
    parasite vaccines, mastitis vaccines, food safety
    vaccines

4
Current Research
  • Member States, Private Bodies, Charities, etc.
  • Review what is being done
  • Establish Inventory of Funding Bodies

5
Proposed Funders
6
ETPGAH Role
  • Governance in place
  • ETPGAH can further develop the SRA and Action
    Plan
  • Monitor progress
  • Review regularly
  • Action Plan to ensure SRA delivers Vision
  • Produce roadmaps milestones
  • Secretariat to monitor progress and act as
    necessary

7
Recommendations for Action
  • Action Plan to be produced following
    consultations with stakeholders and member states
    authorities. These will complement the vision
    document and the SRA.
  • Identify funding sources for the implementation
    of the SRA. This will involve meetings with
    international funders and with the funding
    authorities in the EU and the member states.
  • The recommendations in the SRA will need to be
    discussed with all stakeholders to identify who
    will have responsibility and ownership of the
    different components of the SRA.
  • Once the gap analyses have commenced the results
    will need to be reviewed by the platform in order
    to identify and make recommendations to develop
    specific diseases, technology and science
    programmes to fill the gaps.
  • Once the Action Plan is completed and agreed with
    stakeholders the platform will be responsible for
    monitoring progress and undertaking an annual
    review of activities.
Write a Comment
User Comments (0)
About PowerShow.com